Local symptomatic treatment of certain pain conditions of the middle ear with intact eardrum in children aged 1 month and adults with: otitis media in the acute period; phlyctenules viral otitis media (molegrips); barotraumatic otitis media.
Droplex The composition of the drug:
Droplex active substances: phenazone, lidocaine;
1 ml of the drug contains phenazone 35 mg and lidocaine hydrochloride 8.8 mg;
excipients: sodium thiosulfate, glycerin, ethanol 96%, sodium hydroxide, purified water.
Droplex Dosage form.
Ear drops, solution.
Transparent colorless or slightly yellowish solution.
Name and location of the manufacturer.
K.O. Rompharm Company SRL, Romania, Otopeni, vul. Eroilor № 1A, 075100, Ilfov district.
S.C. «Rompharm Company S.R.L», Romania, Otopeni city, Eroilor str. № 1A, 075100, jud.Ilfov.
The drug for the treatment of ear diseases.
ATC code S02D A30.
Combined drug for topical use in otology with pronounced analgesic and anti-inflammatory effects due to the synergistic action of its components. Lidocaine has a local anesthetic, and phenazone – a pronounced anti-inflammatory effect. Phenazone significantly enhances the local anesthetic effect of lidocaine. The combined use of phenazone and lidocaine reduces the time of onset of the anesthetic effect, while increasing its severity and duration, which allows you to quickly eliminate the pain of otitis.
Indications for use.
For local symptomatic treatment
and anesthesia for:
– acute otitis media;
– otitis as a complication after the flu;
– barotraumatic otitis.
– Violation of the integrity of the eardrum (infectious or traumatic);
– hypersensitivity to the components of the drug.
Appropriate safety precautions for use.
It is recommended to check the integrity of the eardrum before using the drug Droplex. In case of violation of the integrity of the tympanic membrane, the use of Droplex drops is contraindicated.
After instillation, tightly screw the cap and hide the vial in the package to protect the drug from light.
Use during pregnancy or breastfeeding.
There are no data on the safety of Droplex during pregnancy or breastfeeding. The drug is not prescribed to pregnant women, except in situations of absolute necessity and only after assessing the benefits to the mother and the possible risk to the fetus.
There are also no data on the transition of the components of the drug in breast milk. It is recommended to avoid the use of this drug in breastfeeding women.
Ability to influence the speed of reaction when driving a car or working with other mechanisms.
The drug does not affect the ability to drive a car or work with complex equipment that requires special attention.
Apply to children.